Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease

Cornea

Volumn 31, Issue 6, 2012, Pages 680-685

  Nguyen, Pho ^a   Huang, David ^a,b   Li, Yan ^a,b   Sadda, Srinivas R ^a   Ramos, Sylvia ^a   Pappuru, Rajeev R ^a   Yiu, Samuel C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

dry eye disease; optical coherence tomography; rose bengal; Schirmer; symptoms; tear breakup time; tear meniscus

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE SEVERITY; DRY EYE; FEMALE; FOURIER DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HUMAN; LOWER TEAR MENISCUS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHIRMER TEST; SLIT LAMP; SYMPTOM; TEAR FILM;

ADULT; AGED; AGED, 80 AND OVER; CORNEA; DRY EYE SYNDROMES; EYELIDS; FEMALE; FLUORESCEIN; FLUORESCENT DYES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; ROSE BENGAL; TEARS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84862819869     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182261577     Document Type: Article

References (53)

1. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-1268.
2. Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124:723-728.
3. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.
4. Lin PY, Tsai SY, Cheng CY, et al. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2003;110:1096-1101.
5. Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol. 1995;233:555-558.
6. Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86:1347-1351.
7. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114-1119.
8. Savini G, Prabhawasat P, Kojima T, et al. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2:31-55.
9. Jordan A, Baum J. Basic tear flow. Does it exist? Ophthalmology. 1980;87:920-930.
10. Yokoi N, Komuro A. Non-invasive methods of assessing the tear film. Exp Eye Res. 2004;78:399-407.
11. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23:272-285.
12. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-770.
13. Schein OD, Tielsch JM, Munõz B, et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology. 1997;104:1395-1401.
14. Lin PY, Cheng CY, Hsu WM, et al. Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci. 2005;46:1593-1598.
15. Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res. 1996;15:653-661.
16. Saleh TA, McDermott B, Bates AK, et al. Phenol red thread test vs Schirmer's test: a comparative study. Eye. 2006;20:913-915.
17. Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea. 2009;28:732-734.
18. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology. 1999;106:811-816.
19. Tauber J, Davitt WF, Bokosky JE, et al. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea. 2004;23:784-792.
20. Smith RE. The tear film complex: pathogenesis and emerging therapies for dry eyes. Cornea. 2005;24:1-7.
21. Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol. 2004;15:299-304.
22. Yüksel B, Bozdaǧ B, Acar M, et al. Evaluation of the effect of topical cyclosporine A with impression cytology in dry eye patients. Eur J Ophthalmol. 2010;20:675-679.
23. Avni I, Garzozi HJ, Barequet IS, et al. Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial. Ophthalmology. 2010;117:1287-1293.
24. Nguyen P, Yiu SC. Ocular surface reconstruction: recent innovations, surgical candidate selection and postoperative management. Exp Rev Ophthalmol. 2008;3:567-584.
25. Yiu SC, Thomas PB, Nguyen P. Ocular surface reconstruction: recent advances and future outlook. Curr Opin Ophthalmol. 2007;18:509-514.
26. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
27. Huang D, Izatt JA, Yasuno Y, et al. Future direction of anterior segment optical coherence tomography. In: Steinert RF, Huang D, eds. Anterior Segment Optical Coherence Tomography. Thorofare, NJ: SLACK Inc; 2008:165-173.
28. Zhou S, Li Y, Lu AT, et al. Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study. Ophthalmic Surg Lasers Imaging. 2009;40:442-447.
29. Wang J, Aquavella J, Palakuru J, et al. Relationships between central tear film thickness and tear menisci of the upper and lower eyelids. Invest Ophthalmol Vis Sci. 2006;47:4349-4355.
30. Shen M, Li J, Wang J, et al. Upper and lower tear menisci in the diagnosis of dry eye. Invest Ophthalmol Vis Sci. 2009;50:2722-2726.
31. Bitton E, Keech A, Simpson T, et al. Variability of the analysis of the tear meniscus height by optical coherence tomography. Optom Vis Sci. 2007;84:903-908.
32. Savini G, Goto E, Carbonelli M, et al. Agreement between stratus and visante optical coherence tomography systems in tear meniscus measurements. Cornea. 2009;28:148-151.
33. Ibrahim OM, Dogru M, Takano Y, et al. Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease. Ophthalmology. 2010;117:1923-1929.
34. Johnson ME, Murphy PJ. The agreement and repeatability of tear meniscus height measurement methods. Optom Vis Sci. 2005;82:1030-1037.
35. Savini G, Barboni P, Zanini M. Tear meniscus evaluation by optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2006;37:112-118.
36. Nelson JD. In-office diagnostic tests for dry eye disease. In: Asbell PA, Lemp MA, eds. Dry Eye Disease: The Clinician's Guide to Diagnosis and Treatment. New York, NY: Thieme; 2006:34-46.
37. Lin RC, Shure MA, Rollins AM, et al. Group index of the human cornea at 1.3-microm wavelength obtained in vitro by optical coherence domain reflectometry. Opt Lett. 2004;29:83-85.
38. Drexler W, Hitzenberger CK, Baumgartner A, et al. Investigation of dispersion effects in ocular media by multiple wavelength partial coherence interferometry. Exp Eye Res. 1998;66:25-33.
39. Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol. 1998;82:971-973.
40. Sakane Y, Yamaguchi M, Shiraishi A, et al. Evaluation of tear meniscus volume using the DR-1 tear specular scope [in Japanese]. Nippon Ganka Gakkai Zasshi. 2010;114:512-519.
41. Kawai M, Yamada M, Kawashima M, et al. Quantitative evaluation of tear meniscus height from fluorescein photographs. Cornea. 2007;26:403-406.
42. Oguz H, Yokoi N, Kinoshita S. The height and radius of the tear meniscus and methods for examining these parameters. Cornea. 2000;19:497-500.
43. Yuan Y, Wang J, Chen Q, et al. Reduced tear meniscus dynamics in dry eye patients with aqueous tear deficiency. Am J Ophthalmol. 2010;149:932-938.
44. Wang J, Palakuru JR, Aquavella JV. Correlations among upper and lower tear menisci, noninvasive tear break-up time, and the Schirmer test. Am J Ophthalmol. 2008;145:795-800.
45. Kim SE, Yoon JS, Lee SY. Tear measurement in prosthetic eye users with Fourier-domain optical coherence tomography. Am J Ophthalmol. 2010;149:602-607.
46. Wang J, Aquavella J, Palakuru J, et al. Repeated measurements of dynamic tear distribution on the ocular surface after instillation of artificial tears. Invest Ophthalmol Vis Sci. 2006;47:3325-3329.
47. Shen M, Wang J, Tao A, et al. Diurnal variation of upper and lower tear menisci. Am J Ophthalmol. 2008;145:801-806.
48. Wang Y, Zhuang H, Xu J, et al. Dynamic changes in the lower tear meniscus after instillation of artificial tears. Cornea. 2010;29:404-408.
49. Lemp MA. Clinical trials in dry eye in surgery for dry eye? Dev Ophthalmol. 2008;41:283-297.
50. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
51. Begley CG, Caffery B, Chalmers RL, et al. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea. 2002;21:664-670.
52. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108-152.
53. Federal Food, Drug, and Cosmetic Act-FD & C Act, 21 USC § 355 section 505 (d) (1938)